Thinking About Addiction

There are just too many ways to get drugs across borders for a fence or a wall to make that much difference.

Despite the collateral damage, Big Pharma seems determined to preserve the market for its products, through sophisticated lobbying.

From a patient’s viewpoint, physicians can be somewhat blase’ about risks associated with a medication.

It may be that kratom is a drug that some can use without much difficulty, while for others, it becomes pathological.

Willing not only to think outside the box, but to stomp the box flat if need be.

But now we’ll be contending with business interests that actively promote cannabis the way the tobacco and liquor industries promote their products– but with even less restriction

The firm’s managers conclude that sales would be a whole lot better if the disorder were better publicized and more people were diagnosed with it.

We’re talking about legal responsibility now, and that can run far afield from conventional moral judgment.

One in three users reported daily or near-daily consumption, close to triple what it was in the early 1990’s.

Some states have gone bonkers in their haste to make medical pot available for a host of conditions where it likely won’t be of much use.